Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/2003
08/20/2003EP0866693B1 Topically applied, structural cellulite treatments
08/20/2003EP0859591B1 Use of at least one no synthase inhibitor for treating sensitive skin
08/20/2003EP0804615B1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
08/20/2003EP0612248B1 Composition containing cisplatin and topotecan as antitumor agent.
08/20/2003CN1437608A O-aryl glucoside SGL T2 inhibitors and method
08/20/2003CN1437598A Novel indole derivatives
08/20/2003CN1437594A Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/20/2003CN1437485A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1437483A Oral preparations for diabetes
08/20/2003CN1437477A A Memory enhancing protein
08/20/2003CN1437474A Pharmaceutical compositions comprising acryloyl distamycin derivatives and topoisomerase Ôàáand Ôàí inhibitors
08/20/2003CN1437473A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
08/20/2003CN1437470A COX-2 inhibitors and the preventionof the side effects of radiation therapy
08/20/2003CN1437467A Medium chain fatty acids applicable as anitmicrobial agents
08/19/2003US6608177 Mutation of serine replaced with cysteine; use as anti-HIV, anti-allergic or anti- inflammatory agents
08/19/2003US6608109 Replacement for steroids and for stimulating an immune response; in a form which is palatable; acid pH less than 7.0; citric acid
08/19/2003US6608106 Contacting the cell with an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in the cell
08/19/2003US6608101 1, 3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
08/19/2003US6608097 Materials and methods for the treatment of hypertension and angina
08/19/2003US6608094 Breaking preformed AGE
08/19/2003US6608089 Derivatives of flavones, xanthones and coumarins
08/19/2003US6608088 Use of donerezil for the treatment of functional and/or organic pain syndromes
08/19/2003US6608083 Treatment and/or prophylaxis of convulsive disorders, renal disorders, urinary incontinence, ocular inflammation, eating disorders, inflammatory pain, allergic rhinitis, psoriasis,neurodegenerative disorders, Huntington's disease,
08/19/2003US6608078 Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
08/19/2003US6608074 Administering during follicular phase of female menstrual cycle and in luteal phase, a competitive progesterone antagonist, which is less than an ovulation-inhibiting dose and less than an abortion-inductive dose
08/19/2003US6608073 Intranasal codeine for the rapid suppression of cough and rapid relief of pain
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003US6608066 Tissue factor antagonists and methods of use thereof
08/19/2003US6608064 Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas
08/19/2003US6608063 For example: (2-(3-amino-4-nitrophenyl)amino)ethyl)(6-(2,4-dichlorophenyl-5-nitropyrazin -2-yl)-amine; antidiabetic, -carcingenic and ischemic agents; nervous and cardiovascular system disorders; immunotherapy; obesity; syndromes
08/19/2003US6608049 Indazoles
08/19/2003US6608034 Immunovectors for the intracellular and intranuclear transport
08/19/2003US6608031 Peptide comprising specified amino acid sequence
08/19/2003US6608030 Inhibitor of cathepsin S based upon peptide sequence which comprises at least about 2-20 consecutive residues from preferred invariant chain cleavage site of cathepsin S, spanning from residue 68 to residue 90 of specified sequence
08/19/2003US6608029 Reducing gastric motility or delaying gastric emptying in mammal by administering therapeutically effective amount of amylin or amylin agonist, such as pramlintide or pramlintide acetate
08/19/2003US6607893 Measuring diacylglycerol acetyltransferase activity; obtain enzmatic substrate, expose to microsomes, terminate reaction, monitor triglyceride generation
08/19/2003US6607880 Methods and reagents for modulating apoptosis
08/19/2003US6607758 Methods for inhibiting and reducing amyloid fibril formation associated with Alzheimer's Disease and other amyloidoses
08/19/2003US6607749 Non-fermentable methyl cellulose, lipase inhibitor and edible calcium phosphate salt; fecal incontinence, obesity
08/19/2003US6607726 Human tumor necrosis factor receptor TR10
08/19/2003US6607716 Natural treatment for ecto-parasitic infestation, particularly effective against lice be it head, body or pubic. A preferred gel composition includes a salt, a plant essence, and a pharmaceutically acceptable gelling agent.
08/19/2003CA2299972C Thyromimetic antiobesity agents
08/18/2003CA2372535A1 Antitussive compositions
08/15/2003WO2004087941A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/15/2003CA2475206A1 Map-kinase inhibitors as regulators of tumor-associated antigen expression
08/14/2003WO2003067262A2 Methods and compositions involving the hsp90 activator aha1
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066842A2 Method for producing recombinant proteins in micro-organisms
08/14/2003WO2003066841A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003WO2003066822A2 Truncated aggrecanase molecules
08/14/2003WO2003066813A2 MINRs AS MODIFIERS OF INSULIN RECEPTOR SIGNALING AND METHODS OF USE
08/14/2003WO2003066807A2 Method of inhibiting pathogenicity of infectious agents
08/14/2003WO2003066806A2 Therapeutic use of aziridino compounds
08/14/2003WO2003066679A1 Rhamnose binding protein
08/14/2003WO2003066656A1 Crystalline complexes of fluticasone 2-furoate
08/14/2003WO2003066612A1 Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them
08/14/2003WO2003066606A1 Salts of valsartan
08/14/2003WO2003066603A1 Quinazolinone derivatives and their use as cb agonists
08/14/2003WO2003066601A1 Pyrimidine compounds
08/14/2003WO2003066595A2 2 - piperazine - pyridines useful for treating pain
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066165A1 Tumor necrosis factor combined with interferon in demyelinating diseases
08/14/2003WO2003066091A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7
08/14/2003WO2003066087A2 Kinases involved in the regulation of energy homeostasis
08/14/2003WO2003066077A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
08/14/2003WO2003066071A1 Formulations comprising psychotropic drugs and selenium
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003WO2003066064A2 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics
08/14/2003WO2003066063A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/14/2003WO2003066061A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
08/14/2003WO2003066059A1 Treatment of neuroblastoma
08/14/2003WO2003066056A1 Method of promoting neuronal growth
08/14/2003WO2003066055A1 Quinoline derivatives as npy antagonists
08/14/2003WO2003066052A1 Anticancer agent comprising nitroimidazole and topoisomerase inhibitor as active ingredients
08/14/2003WO2003066048A2 Use of 15-lipoxygenase inhibitors for treating and preventing bone loss
08/14/2003WO2003066044A1 New medicinal compositions containing heterocyclical compounds in addition to anticholinergics
08/14/2003WO2003066043A1 Stimulation of cpt-1 as a means to reduce weight
08/14/2003WO2003066040A1 Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
08/14/2003WO2003066039A1 Combination therapy for treatment of schizophrenia
08/14/2003WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003066033A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
08/14/2003WO2003066030A2 Pharmaceutical tablet
08/14/2003WO2003066021A2 Drug nanoparticles with lysozyme surface stabiliser
08/14/2003WO2003066020A1 Composition for easing human childbirth
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065994A2 Schwann cell and phosphodiesterase inhibitors based therapy
08/14/2003WO2003065992A2 Treating benign prostate hyperplasia with sarms
08/14/2003WO2003065988A2 A combination for treating cold and cough
08/14/2003WO2003065987A2 Granzyme b inhibitors
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065984A2 Methods and compositions for treating cardiovascular disease
08/14/2003WO2003065983A2 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/14/2003WO2003065980A2 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin
08/14/2003WO2003065924A1 Control of a biological function
08/14/2003WO2003065871A2 Methods and compositions for treating hematological disorders
08/14/2003WO2003043647A3 A plant extract active as an immunostimulating agent
08/14/2003WO2003031568A8 Intracellular signaling molecules
1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 1151